Intuitive Surgical (ISRG) Expected to Announce Quarterly Earnings on Tuesday

Key Points

• Intuitive Surgical is set to announce its Q3 2025 earnings on Tuesday, October 21, with analysts predicting earnings of $2.00 per share and revenue of $2.4075 billion.
• The company recently reported Q2 2025 earnings of $2.19 per share, exceeding expectations by $0.26, alongside a 21.4% year-over-year revenue increase to $2.44 billion.
• Insider trading activity showed significant stock sales by executives, with insiders collectively selling over $21 million worth of shares in the last quarter.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) is expected to announce its Q3 2025 results after the market closes on Tuesday, October 21st. Analysts expect the company to announce earnings of $2.00 per share and revenue of $2.4075 billion for the quarter. Parties may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Tuesday, October 21, 2025 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the business posted $1.78 EPS. The company's revenue for the quarter was up 21.4% on a year-over-year basis. On average, analysts expect Intuitive Surgical to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Intuitive Surgical Stock Up 1.4%

Shares of ISRG stock opened at $435.73 on Tuesday. Intuitive Surgical has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a market cap of $156.20 billion, a PE ratio of 60.77, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. The stock has a 50 day moving average of $457.73 and a 200-day moving average of $497.44.

Insiders Place Their Bets

In related news, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. Company insiders own 0.70% of the company's stock.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in the company. California State Teachers Retirement System grew its holdings in shares of Intuitive Surgical by 1.8% in the 2nd quarter. California State Teachers Retirement System now owns 560,780 shares of the medical equipment provider's stock worth $304,733,000 after purchasing an additional 10,074 shares during the last quarter. Oxford Financial Group LTD. LLC boosted its position in Intuitive Surgical by 72.7% in the second quarter. Oxford Financial Group LTD. LLC now owns 330,527 shares of the medical equipment provider's stock valued at $179,612,000 after buying an additional 139,158 shares in the last quarter. Corient Private Wealth LLC boosted its position in Intuitive Surgical by 72.2% in the second quarter. Corient Private Wealth LLC now owns 309,759 shares of the medical equipment provider's stock valued at $167,426,000 after buying an additional 129,854 shares in the last quarter. AQR Capital Management LLC grew its stake in Intuitive Surgical by 211.2% during the second quarter. AQR Capital Management LLC now owns 158,410 shares of the medical equipment provider's stock worth $85,741,000 after buying an additional 107,504 shares during the last quarter. Finally, State of Tennessee Department of Treasury increased its holdings in shares of Intuitive Surgical by 7.4% during the second quarter. State of Tennessee Department of Treasury now owns 137,927 shares of the medical equipment provider's stock worth $74,951,000 after buying an additional 9,514 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ISRG shares. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, October 4th. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Truist Financial lifted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Finally, Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Fourteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $584.76.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.